Screening for Type 2 Diabetes > Referral/Consultation Author: Lorraine Lipscombe, MD, FRCPC; Denice S. Feig, MD, MSc, FRCPC
Editorial changes - 2012-02-07
Author information and module status
Key Points
Population at Risk
Effectiveness/Harms of Screening Tests
Effectiveness/Harms of Early Treatment
Direct Evidence that Screening Reduces Adverse Outcomes
Timeline
Cost-Effectiveness
Patient Education
Referral/Consultation
Guidelines
Tables
References
Glossary
What's New
Patient Information
Additional Resources
Tools
Recommendation
Refer all patients with evidence of type 1 diabetes for consultation with an endocrinologist or diabetes specialist.B

Evidence:

  • A prospective study of type 1 diabetes patients found that those who received specialist care for their diabetes had significantly lower HbA1c levels than those who did not (9.7% vs. 10.3%; P = 0.0006). These patients were also more likely to have received diabetes education, to have an HbA1c test in the previous 6 months, to self-monitor their glucose levels, and to inject insulin more than twice daily than those who did not receive specialist care (144).
  • Specialist care may also be protective against the development of complications in this population, with a trend towards decreased nephropathy, neuropathy, and CVD (145).

Comments:

  • None.

FAQs
Denice S. Feig, MD, MSc, FRCPC has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Lorraine Lipscombe, MD, FRCPC has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Sonal Singh, MD, editorial consultant, has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
Deborah Korenstein, MD, FACP, Co-Editor, PIER, has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Richard B. Lynn, MD, FACP, Co-Editor, PIER, has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.

The information included herein should never be used as a substitute for clinical judgment and does not represent an official position of ACP. Because all PIER modules are updated regularly, printed web pages or PDFs may rapidly become obsolete. Therefore, PIER users should compare the date of the last update on the website with any printout to ensure that the information being referred to is the most current available.
PIER is copyrighted © 2012 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.